Chemed Corporation — Revenue by Fiscal Year

18 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/71765b1c-a67e-4faf-a254-6342c459bbee/serie/revenue

Fiscal year	Revenue	Period	Evidence
FY 2025	$2.5B	2025-01-01 – 2025-12-31	evidence 0001562762-26-000020
FY 2024	$2.4B	2024-01-01 – 2024-12-31	evidence 0001562762-26-000020
FY 2023	$2.3B	2023-01-01 – 2023-12-31	evidence 0001562762-26-000020
FY 2022	$1.2B	2022-01-01 – 2022-12-31	evidence 0001562762-23-000057
FY 2021	$1.3B	2021-01-01 – 2021-12-31	evidence 0001562762-22-000060
FY 2020	$1.3B	2020-01-01 – 2020-12-31	evidence 0000019584-21-000003
FY 2019	$1.3B	2019-01-01 – 2019-12-31	evidence 0000019584-20-000006
FY 2018	$1.2B	2018-01-01 – 2018-12-31	evidence 0001157523-19-000468
FY 2017	$1.7B	2017-01-01 – 2017-12-31	evidence 0001157523-19-000468
FY 2016	$1.6B	2016-01-01 – 2016-12-31	evidence 0001157523-19-000468
FY 2015	$1.5B	2015-01-01 – 2015-12-31	evidence 0001157523-16-004755
FY 2014	$1.5B	2014-01-01 – 2014-12-31	evidence 0001157523-15-000756
FY 2013	$1.4B	2013-01-01 – 2013-12-31	evidence 0001157523-14-000846
FY 2012	$1.4B	2012-01-01 – 2012-12-31	evidence 0001157523-13-001064
FY 2011	$1.4B	2011-01-01 – 2011-12-31	evidence 0001157523-12-001051
FY 2010	$1.3B	2010-01-01 – 2010-12-31	evidence 0000950123-11-019686
FY 2009	$1.2B	2009-01-01 – 2009-12-31	evidence 0000950123-11-019686
FY 2008	$1.1B	2008-01-01 – 2008-12-31	evidence 0000950123-11-019686

Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Chemed Corporation — all facts · Net Income · Operating Income